Sequentia Biotech

Sequentia Biotech (www.sequentiabiotech.com) was founded in 2013 by Walter Sanseverino (CEO) and Riccardo Aiese Cigliano (CSO), two young researchers with a real passion for genetics and omics sciences, as a spin-off of the Centre for Research in Agricultural Genomics (CRAG), a consortium composed by CSIC, IRTA, UAB and the UB. The objective of Sequentia Biotech is to create proprietary know-how to increase the access of the scientific community to the information produced by new generation sequencing technologies (Next Generation Sequencing, NGS) efficiently and affordably. The company based in the Parc Cientific de Barcelona from UB and in the Parc de Recerca from UAB, focuses its work on the design and development of new bioinformatic tools for the analysis and integration of genomic and post-genomic data that expedite basic and applied research. Currently, and just three years since its inception, Sequentia has achieved a large highly diversified portfolio of clients and partners, consisting of over 30 public and private research centers, companies and hospitals. The company is taking part in more than 160 R & D public and private projects; and it has two open source biodata banks. Cofounders Walter Sanseverino and Riccardo Aiese have published more than 40 scientific articles in high impact journals such as Nature Genetics, Scientific Report or DNA Research.